Peptide record

TPDB09206

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09206
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb
standard
No
A 19-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLSLIPHAINAVSTLVHHF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C101H154N26O24
RDCEQGKMWY
HL
2116.49
8.09
3
0
11
+0
-0.65
1.105
143.68
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
4
Residue Composition
number
2
A
0
R
1
N
0
D
0
C
0
E
0
Q
0
G
3
H
2
I
3
L
0
K
0
M
2
F
1
P
2
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 3 I: 2 L: 3 K: 0 M: 0 F: 2 P: 1 S: 2 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
19 reviewed residue count
C101H154N26O24 sequence-only estimate (linear, free termini)
2116.49 sequence-only estimate (linear, free termini)
8.09 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
-0.65 sequence-only estimate (linear, free termini)
1.105 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:15752569]0.1% hemolytic activity at 4 µM, 0.28% hemolytic activity at 4 µM, 0.7% hemolytic activity at 8 µM, 0.8% hemolytic activity at 16 µM, 1.05% hemolytic activity at 32 µM, 2.05% hemolytic activity at 64 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2005 Apr 26(4):565-573.##Peptides. 2008 Oct 29(10):1633-1644.